Vivek Ramaswamy has an estimated net worth of $600 million.
Advertisement
Vivek was included in the 2016 list of America’s Richest Entrepreneurs Under 40 on Forbes.
Ramaswamy made his fortune in biotech investing.
He was behind the biggest biotechnology initial public offering of 2016, Myovant Sciences, which raised $218 million listing its shares on Nasdaq in October.
Ramaswamy later formed the company in April and struck a deal with Takeda Pharmaceuticals for a prostate cancer drug and a female infertility drug.
Advertisement
Photo Credit: Politico
Vivek founded Roivant Sciences in 2014, the company currently has a net worth valued at $6.54 billion.
In 2022, he co-founded Strive Asset Management, a assent management firm, which, according to his website, is focused on “restoring the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics”.
It was launched with backing from billionaire investors including Peter Thiel and Bill Ackman.
In 2007, Ramaswamy and Travis May co-founded Campus Venture Network, a technology company that provided software and networking resources to university entrepreneurs.
Leave a Reply